DOSAGE FORMS & STRENGTHS SECTION
1ml
1ml
| Class | Version | Type | Effective |
|---|---|---|---|
| CHOLINE C-11 Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| a1acfa67-deca-4d07-9fa2-83d3856a0e25 | Product name | 4 | 20180131 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 70104-806-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-d729-f424-e053-dadaa90a57ce | 253ca66e-3c25-0483-e054-00144ff8d46c |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70104-806-01 | MIC B12 | 1 mL in 1 VIAL | INJECTION | 1 | 1 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CHOLINE C-11 | ACTIVE INGREDIENT | M4AS4XGD4Q | 1 | |
| INOSITOL | ACTIVE INGREDIENT | 4L6452S749 | 1 | |
| L-METHIONINE-S,R-SULFOXIMINE | ACTIVE INGREDIENT | M9P6YZ6JX9 | 1 | |
| METHYLCOBALAMIN | ACTIVE INGREDIENT | BR1SN1JS2W | 1 | |
| CHOLINE C-11 | ACTIVE MOIETY | M4AS4XGD4Q | 1 | |
| INOSITOL | ACTIVE MOIETY | 4L6452S749 | 1 | |
| L-METHIONINE-S,R-SULFOXIMINE | ACTIVE MOIETY | M9P6YZ6JX9 | 1 | |
| METHYLCOBALAMIN | ACTIVE MOIETY | BR1SN1JS2W | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 70104-806 | 70104-806-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| INOSITOL | 4L6452S749 | ACTIB |
| CHOLINE C-11 | M4AS4XGD4Q | ACTIB |
| METHYLCOBALAMIN | BR1SN1JS2W | ACTIB |
| L-METHIONINE-S,R-SULFOXIMINE | M9P6YZ6JX9 | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 253ca66e-3c26-0483-e054-00144ff8d46c | 253ca66e-3c25-0483-e054-00144ff8d46c | 2015-11-23 | 253ca66e-3c26-0483-e054-00144ff8d46c 253ca66e-3c25-0483-e054-00144ff8d46c |
Adverse event summaries are temporarily unavailable. Other product information remains available.